Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity.
Journal: Science immunology
Published: April 26, 2024
Creating and Implementing a Community-Focused, Culturally Tailored Health Marketing Campaign to Address Menthol Cigarette Use in Los Angeles County.
Journal: Preventing chronic disease
Published: April 18, 2024
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).
Journal: Journal for immunotherapy of cancer
Published: August 20, 2022
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce.
Journal: Journal for immunotherapy of cancer
Published: March 05, 2020
Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 10, 2019
CCR 20th Anniversary Commentary: Immune-Related Response Criteria--Capturing Clinical Activity in Immuno-Oncology.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 15, 2015
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.
Journal: Annals of the New York Academy of Sciences
Published: June 19, 2013
Exposure-response relationships of the efficacy and safety of ipilimumab in patients with advanced melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 07, 2013
Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 14, 2013
Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models.
Journal: Cancer immunology, immunotherapy : CII
Published: January 02, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026